Global Insulin Pump Market will be US$ 16 Billion by 2025
23 Jan, 2020

Insulin pumps are portable automated medical devices that can be connected below the clothes to a belt. Based on the basal and bolus rate of the user, the pump is used to administer regulated doses of insulin within the body at regular intervals to control the increased blood glucose levels. This works by means of a needle and a flexible catheter used to directly inject insulin into the fatty tissue, which is then wrapped and held in place. Insulin pumps help people with type 1 and type 2 diabetes by providing them with consistency in food options and feeding schedules and reducing the number of injection procedures. Global Insulin Pump Market is expected to surpass US$ 16 Billion by the end of year 2025.

 

Global Insulin Pump Market, Users, Forecast, Reimbursement Policy Countries (United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom, Japan, Kuwait, Saudi Arabia, Italy and Span) Clinical Trials, Training Model, Company Analysis is the 3rd edition report published by Renub Research on Insulin Pump Market.

The major factors that influence the market growth are; increasing per capita income, increasing healthcare infrastructure, rising diabetes awareness, increasing prevalence of type 1 diabetes, increasing day to day complication in diabetes management, growing awareness regarding diabetes, improving reimbursement policies, insurance coverage, great contribution of non-profit organization, advancement of technology, ease of use, discovery of tiny patch pump, increasing use of insulin pump over traditional methods of managing diabetes, increasing use of less invasive technology etc. insulin pumps are very convenient for people who need multiple daily insulin injections.

 

Request a free Brochure copy of the report:  https://www.renub.com/request-brochure-page.php?gturl=insulin-pump-market-and-forecast-worldwide-analysis-127-p.php

 

Market Summary:

By Diabetes Population: This report provides a complete picture of diabetes population, type1 diabetes, and type2 diabetes. It also explains the various factors why the diabetes population is increasing all over the world.

By Reimbursement Policies: This report gives a complete framework of reimbursement policies by countries specific. It also provides insight why reimbursement policies of insulin pump are expanding over period of time.

By Training Model: This subject illustrates how a company provides training through the flowchart process. This section company training plan for its employees includes physicians, Certified Diabetes Educators (including nurse educators, dietitians and physiologists for exercise).

By Regions: Complete Regional analysis has been done to provide all the detailed picture of insulin pump by each and every country covered in the report. the country include in this report are; United States, Canada, Germany, France, Netherlands, Switzerland, Sweden, United Kingdom, Italy, Spain, Kuwait, Saudi Arabia, Australia, Israel and Japan.

By Companies: The study provides a full assessment of leading players along with overview, sales analysis, and business strategy; Medtronic, Henry Schein, and Tandem Diabetes Care.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

1.    Introduction
2.    Research Methodology

3.    Executive Summary
4.    Growth Drivers

4.1    Point no. 1
4.2    Point no. 2

5.    Challenges

5.1    Point no. 1
5.2    Point no. 2

6.    Global – Insulin Pump Users & Forecast

7.    Global – Insulin Pump Market & Forecast

8.    Global – Insulin Pump Market Share & Forecast

8.1    By 11 Countries – United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada
8.2    Market Share Global Tube Pump Market & Global Patch Pump Market
8.3    User Share

9.    Training Model for Patients & HCP – of Medtronic, Insulet Corp & Tandem Diabetes Care

9.1    Medtronic
9.2    Insulet Corporation
9.3    Tandem Diabetes Care

10.    Differentiation Points of Insulin Pump Products Available Worldwide

10.1    Medtronic 530G with Enlite
10.2    Insulet OmniPod
10.3    Tandem t:slim
10.4    Roche Accu-Chek Combo

11.    United States Diabetes Population (2011 – 2025)

12.    United States – Insulin Pump Market Analysis (2011 – 2025)

12.1    Insulin Pump User & Forecast
12.2    Insulin Pump Market & Forecast
12.3    By States – Reimbursement Policies on Insulin Pump

13.    Canada – Diabetes Analysis (2011 – 2025)

13.1    Canada Diabetes Population & Forecast
13.2    Type 1 & Type 2 Diabetes Population & Forecast

14.    Canada Insulin Pump Analysis (2011 – 2025)

14.1    Insulin Pump Users & Forecast
14.2    Insulin Pump Market (2011 – 2025)
14.3    By Province – Insulin Pump Reimbursement policy

15.    Germany – Diabetes Analysis (2011 – 2025)

15.1    Germany Diabetes Population (2011 – 2025)

16.    Germany Insulin Pump Analysis (2011 – 2025)

16.1    Insulin Pump Users
16.2    Germany Insulin Pump Market & Forecast
16.3    Reimbursement Policies on Insulin Pump

17.    Australia Diabetes Population (2011 – 2025)

17.1    Type 1 & Type 2 Diabetes Population and Forecast

18.    Australia Insulin Pump Analysis (2011 – 2025)

18.1    Insulin Pump Users & Forecast
18.2    Insulin Pump Market & Forecast
18.3    Reimbursement Policies on Insulin Pump

19.    France – Diabetes Analysis (2011 – 2025)

19.1    France Diabetes Population & Forecast
19.2    Type 1 & Type 2 Diabetes Population & Forecast

20.    France Insulin Pump Analysis (2011 – 2025)

20.1    Insulin Pump Users & Forecast
20.2    Insulin Pump Market & Forecast
20.3    Reimbursement Policies on Insulin pump

21.    Netherlands – Diabetes Analysis (2011 – 2025)

21.1    Netherlands Diabetes Population (2011 – 2025)

22.    Netherlands Insulin Pump Analysis (2011 – 2025)

22.1    Insulin Pump Users & Forecast
22.2    Insulin Pump Market & Forecast
22.3    Reimbursement Policies on Insulin Pump

23.    Switzerland – Diabetes Analysis (2011 – 2025)

23.1    Switzerland Diabetes Population (2011 – 2025)

24.    Switzerland Insulin Pump Analysis (2011 – 2025)

24.1    Insulin Pump Users & Forecast
24.2    Insulin Pump Market & Forecast
24.3    Reimbursement Policies on Insulin Pump

25.    Sweden – Diabetes Analysis (2011 – 2025)

25.1    Sweden Diabetes Population (2011 – 2025)

26.    Sweden Insulin Pump Analysis (2011 – 2025)

26.1    Insulin Pump Users & Forecast
26.2    Insulin Pump Market & Forecast
26.3    Reimbursement Policies on Insulin Pump

27.    Israel – Diabetes Analysis (2011 – 2025)

27.1    Israel Diabetes Population & Forecast
27.2    Type 1 Diabetes Population & Forecast

28.    Israel Insulin Pump Analysis (2011 – 2025)

28.1    Insulin Pump Users & Forecast
28.2    Insulin Pump Market & Forecast
28.3    Reimbursement Policies on Insulin Pump

29.    United Kingdom – Diabetes Analysis (2011 – 2025)

29.1    United Kingdom Diabetes Population (2011 – 2025)

30.    United Kingdom Insulin Pump Analysis (2011 – 2025)

30.1    Insulin Pump Users & Forecast
30.2    Insulin Pump Market & Forecast
30.3    Reimbursement Policies on Insulin Pump

31.    Japan – Diabetes Analysis (2011 – 2025)

31.1    Japan Diabetes Population & Forecast
31.2    Type 1 & Type 2 Diabetes Population & Forecast

32.    Japan Insulin Pump Analysis (2011 – 2025)

32.1    Insulin Pump Users & Forecast
32.2    Insulin Pump Market & Forecast
32.3    Reimbursement Policies on Insulin Pump

33.    Kuwait – Diabetes Analysis (2011 – 2025)

33.1    Kuwait Diabetes Population (2011 – 2025)

34.    Kuwait Insulin Pump Analysis (2011 – 2025)

34.1    Insulin Pump Users & Forecast
34.2    Insulin Pump Market (2011 – 2025)
34.3    Reimbursement Policies on Insulin pump

35.    Saudi Arabia - Diabetes Analysis (2011 – 2025)

35.1    Saudi Arabia Diabetes Population & Forecast

36.    Saudi Arabia Pump Analysis (2011 – 2025)

36.1    Insulin Pump Users & Forecast
36.2    Insulin Pump Market (2011 – 2025)
36.3    Reimbursement of Diabetes Devices in Saudi Arabia

37.    Spain

37.1    Spain Diabetes Population (2011 – 2025)

38.    Spain Insulin Pump Analysis (2011 – 2025)

38.1    Insulin Pump Users & Forecast
38.2    Insulin Pump Market & Forecast
38.3    Reimbursement Policies on Insulin Pump

39.    Italy

39.1    Italy Diabetes Population (2011 – 2025)

40.    Italy Insulin Pump Analysis (2011 – 2025)

40.1    Insulin Pump Users & Forecast
40.2    Insulin Pump Market & Forecast
40.3    Reimbursement Policies on Insulin Pump

41.    Key Companies Analysis

41.1    Medtronic
41.2    Insulet Corporation
41.3    Tandem Diabetes Care
41.4    Roche Diagnosti

42.    Companies - Insulin Pump Clinical Trials

42.1    Medtronic
42.2    Insulet Corporation
42.3    Tandem Diabetes Care
42.4    Roche

43.    Appendix

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research